BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28975182)

  • 1. Radionuclides in oncology clinical practice - review of the literature.
    Luna Pais H; Alho I; Vendrell I; Mansinho A; Costa L
    Dalton Trans; 2017 Oct; 46(42):14475-14487. PubMed ID: 28975182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cancer radiopharmaceuticals.
    Hoefnagel CA
    Anticancer Drugs; 1991 Apr; 2(2):107-32. PubMed ID: 1958857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic radionuclides in nuclear medicine: current and future prospects.
    Yeong CH; Cheng MH; Ng KH
    J Zhejiang Univ Sci B; 2014 Oct; 15(10):845-63. PubMed ID: 25294374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radionuclides and carrier molecules for therapy.
    Zweit J
    Phys Med Biol; 1996 Oct; 41(10):1905-14. PubMed ID: 8912370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy.
    Ting G; Chang CH; Wang HE; Lee TW
    J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20811605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radionuclide therapy in oncology: the dawning of its concomitant use with other modalities?
    Valdés Olmos RA; Hoefnagel CA
    Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):929-31. PubMed ID: 15042326
    [No Abstract]   [Full Text] [Related]  

  • 7. [Radionuclide therapy of malignant and benign extra-thyroid diseases].
    zum Winkel K
    Onkologie; 1982 Apr; 5(2):67-75. PubMed ID: 6285243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radionuclide therapy revisited.
    Hoefnagel CA
    Eur J Nucl Med; 1991; 18(6):408-31. PubMed ID: 1879447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
    Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
    Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular targeting with radionuclides: state of the science.
    Britz-Cunningham SH; Adelstein SJ
    J Nucl Med; 2003 Dec; 44(12):1945-61. PubMed ID: 14660721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted radiotherapy using Auger electron emitters.
    O'Donoghue JA; Wheldon TE
    Phys Med Biol; 1996 Oct; 41(10):1973-92. PubMed ID: 8912375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiobiologic principles in radionuclide therapy.
    Kassis AI; Adelstein SJ
    J Nucl Med; 2005 Jan; 46 Suppl 1():4S-12S. PubMed ID: 15653646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovation, Impact, and Strategic Importance of Alpha-Emitting Radionuclides.
    Mirzadeh S
    J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S21-S25. PubMed ID: 31420270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor radionuclide therapy of tumors: a road from basic research to clinical applications.
    Bodei L; Paganelli G; Mariani G
    J Nucl Med; 2006 Mar; 47(3):375-7. PubMed ID: 16513604
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted Radiotherapy with Alpha-Particle Emitting Radionuclides Seminar, November 18, 2004, Cracow, Poland.
    Zalutsky MR; Petelenz B
    Nucl Med Rev Cent East Eur; 2004; 7(2):195. PubMed ID: 15968616
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic radiation therapy with unsealed radionuclides.
    McDougall IR
    Semin Radiat Oncol; 2000 Apr; 10(2):94-102. PubMed ID: 10727598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of nuclear medicine to the therapy of malignant tumors.
    Feinendegen LE
    Strahlenther Onkol; 1991 Nov; 167(11):619-27. PubMed ID: 1962275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear localizing sequences: an innovative way to improve targeted radiotherapy.
    O'Donnell RT
    J Nucl Med; 2006 May; 47(5):738-9. PubMed ID: 16644741
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends.
    Steiner M; Neri D
    Clin Cancer Res; 2011 Oct; 17(20):6406-16. PubMed ID: 22003068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proposed methodology to select radioisotopes for use in radionuclide therapy.
    Cuaron JJ; Hirsch JA; Medich DC; Rosenstein BS; Martel CB; Hirsch AE
    AJNR Am J Neuroradiol; 2009 Nov; 30(10):1824-9. PubMed ID: 19661172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.